Saptalis Pharmaceuticals is launching fluoxetine oral solution 20 mg/5 ml, a prescription-only selective serotonin reuptake ...

Demand for potassium sorbate is on track to experience a steady rise, with its industry value estimated to reach USD 69.8 ...

Oral anticoagulants (OACs) are medications commonly used in patients with atrial fibrillation and other cardiovascular conditions. Both warfarin and direct oral anticoagulants are susceptible to ...

Marksans Pharma announced that its wholly owned subsidiary Relonchem has received marketing authorization for the product Oxybutynin hydrochloride Oral Solution from UK Medicines & Healthcare Products ...

HAUPPAUGE, N.Y., June 18, 2025--Saptalis Pharmaceuticals, LLC. is pleased to announce the commercial launch of Fluoxetine Oral Solution, USP 20 mg/5 mL, a prescription-only selective serotonin ...

Fluoxetine Oral Solution, USP 20 mg/5 mL is available by prescription and should only be used under the guidance of a licensed healthcare provider to ensure safe and effective treatment.

In the coming years, the losartan potassium API market size is expected to see even stronger growth. By 2029, the market size is forecasted to reach $2.44 billion, expanding at a CAGR of 6.9%.

Fluoxetine Oral Solution, USP 20 mg/5 mL is available by prescription and should only be used under the guidance of a licensed healthcare provider to ensure safe and effective treatment. For full ...

Xywav (calcium, magnesium, potassium and sodium oxybates) oral solution. Prescribing Information. Palo Alto, CA: Jazz Pharmaceuticals, Inc. 2021. United States Drug Enforcement Agency.